Jazz Pharmaceuticals (JAZZ) Current Taxes (2012 - 2026)
Jazz Pharmaceuticals' quarterly Current Taxes came in at $93.7 million in Q1 2026, up 195.01% year-on-year from $31.8 million in Q1 2025, and up 66.43% quarter-over-quarter from $56.3 million in Q4 2025.
Jazz Pharmaceuticals has reported Current Taxes for 15 years, with the latest figure at $93.7 million in Q1 2026.
- For the quarter ending Q1 2026, Current Taxes rose 195.01% year-over-year to $93.7 million; the trailing twelve-month figure through Mar 2026 stood at $93.7 million (up 195.01% YoY), and the FY2025 full-year result was $56.3 million, up 200.15% from the prior year.
- Current Taxes for Q1 2026 stood at $93.7 million, up from $56.3 million in the prior quarter.
- The five-year high for Current Taxes was $93.7 million in Q1 2026, with the low at $5.8 million in Q2 2022.
- Average Current Taxes over 5 years is $47.6 million, with a median of $49.3 million recorded in 2024.
- Year-over-year, Current Taxes tumbled 69.51% in 2022 and surged 1065.1% in 2023.
- Tracing JAZZ's Current Taxes over 5 years: stood at $7.7 million in 2022, then surged by 354.5% to $35.1 million in 2023, then sank by 46.52% to $18.8 million in 2024, then jumped by 200.15% to $56.3 million in 2025, then jumped by 66.43% to $93.7 million in 2026.
- The last three Current Taxes figures came in at $93.7 million (Q1 2026), $56.3 million (Q4 2025), and $91.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 10,460.56 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 19.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | 93.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.70 Mn |
| Dec 31, 2025 | 56.30 Mn |
| Sep 30, 2025 | 91.14 Mn |
| Jun 30, 2025 | 78.55 Mn |
| Mar 31, 2025 | 31.76 Mn |
| Dec 31, 2024 | 18.76 Mn |
| Sep 30, 2024 | 54.97 Mn |
| Jun 30, 2024 | 52.14 Mn |
| Mar 31, 2024 | 49.33 Mn |
| Dec 31, 2023 | 35.07 Mn |
| Sep 30, 2023 | 89.03 Mn |
| Jun 30, 2023 | 67.53 Mn |
| Mar 31, 2023 | 40.10 Mn |
| Dec 31, 2022 | 7.72 Mn |
| Sep 30, 2022 | 10.44 Mn |
| Jun 30, 2022 | 5.80 Mn |
| Mar 31, 2022 | 26.68 Mn |
| Dec 31, 2021 | 9.61 Mn |
| Sep 30, 2021 | 34.26 Mn |
| Jun 30, 2021 | 3.65 Mn |
| Mar 31, 2021 | 49.33 Mn |
| Dec 31, 2020 | 25.20 Mn |
| Sep 30, 2020 | 25.91 Mn |
| Jun 30, 2020 | 55.98 Mn |
| Mar 31, 2020 | 31.21 Mn |
| Dec 31, 2019 | 10.97 Mn |
| Sep 30, 2019 | 43.49 Mn |
| Jun 30, 2019 | 30.41 Mn |
| Mar 31, 2019 | 40.83 Mn |
| Dec 31, 2018 | 1.20 Mn |
| Sep 30, 2018 | 7.14 Mn |
| Jun 30, 2018 | 17.93 Mn |
| Mar 31, 2018 | 36.05 Mn |
| Dec 31, 2017 | 21.58 Mn |
| Sep 30, 2017 | 13.60 Mn |
| Jun 30, 2017 | 7.49 Mn |
| Mar 31, 2017 | 35.30 Mn |
| Dec 31, 2016 | 4.51 Mn |
| Sep 30, 2016 | 5.22 Mn |
| Jun 30, 2016 | 1.76 Mn |
| Mar 31, 2016 | 19.74 Mn |
| Dec 31, 2015 | 1.81 Mn |
| Sep 30, 2015 | 16.36 Mn |
| Jun 30, 2015 | 13.46 Mn |
| Mar 31, 2015 | 26.33 Mn |
| Dec 31, 2014 | 7.59 Mn |
| Sep 30, 2014 | 15.76 Mn |
| Jun 30, 2014 | 5.50 Mn |
| Mar 31, 2014 | 824,000.00 |
| Dec 31, 2013 | 336,000.00 |
| Sep 30, 2013 | 19.85 Mn |
| Jun 30, 2013 | 17.54 Mn |
| Mar 31, 2013 | 37.80 Mn |
| Dec 31, 2012 | 39.88 Mn |
| Jun 30, 2012 | 7.18 Mn |